Skip to main content
Erschienen in: Current Geriatrics Reports 3/2014

01.09.2014 | Geriatric Oncology (TM Wildes, Section Editor)

Models of Care in Geriatric Oncology

verfasst von: Allison Magnuson, William Dale, Supriya Mohile

Erschienen in: Current Geriatrics Reports | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

The highest incidence of cancer occurs among older adults, and the approach to cancer treatment and supportive measures in this age group is continuously evolving. Incorporating geriatric assessment (GA) into the care of the older patient with cancer has been shown to be feasible and predictive of outcomes; there are unique aspects of the traditional geriatric domains that can be considered in this population. Geriatric assessment-guided interventions can also be developed to support patients during their treatment course. There are several existing models of incorporating geriatrics into oncology care, including a consultative geriatric assessment, a geriatrician “embedded” within an oncology clinic, and primary management by a dual-trained geriatric oncologist. Although the geriatric assessment is led by a geriatrician or geriatric oncologist, it is a true multidisciplinary assessment, and often includes evaluation by a physical therapist, occupational therapist, pharmacist, social worker, and nutritionist.
Literatur
1.
Zurück zum Zitat Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300.PubMedCrossRef Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60(5):277–300.PubMedCrossRef
2.
Zurück zum Zitat Hutchins LF, Unger JM, Crowley JJ, Coltman Jr CA, Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341(27):2061–7.PubMedCrossRef Hutchins LF, Unger JM, Crowley JJ, Coltman Jr CA, Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341(27):2061–7.PubMedCrossRef
3.
Zurück zum Zitat Wildiers H, Mauer M, Pallis A, et al. End points and trial design in geriatric oncology research: a joint European organisation for research and treatment of cancer–Alliance for Clinical Trials in Oncology–International Society Of Geriatric Oncology position article. J Clin Oncol. 2013;31(29):3711–8.PubMedCrossRef Wildiers H, Mauer M, Pallis A, et al. End points and trial design in geriatric oncology research: a joint European organisation for research and treatment of cancer–Alliance for Clinical Trials in Oncology–International Society Of Geriatric Oncology position article. J Clin Oncol. 2013;31(29):3711–8.PubMedCrossRef
4.••
Zurück zum Zitat Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011;29(25):3457–65. This article demonstrates the predictive ability of GA.PubMedCentralPubMedCrossRef Hurria A, Togawa K, Mohile SG, et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol. 2011;29(25):3457–65. This article demonstrates the predictive ability of GA.PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat O'Donovan A. Geriatric assessment for older adults with cancer: an international delphi study/an expert consensus panel on geriatric assessment interventions in oncology: the european perspective. J Geriatr Oncol. 2013;4(Supplement 1):S14–5.CrossRef O'Donovan A. Geriatric assessment for older adults with cancer: an international delphi study/an expert consensus panel on geriatric assessment interventions in oncology: the european perspective. J Geriatr Oncol. 2013;4(Supplement 1):S14–5.CrossRef
6.
Zurück zum Zitat Dale W, Mohile SG, Eldadah BA, et al. Biological, clinical, and psychosocial correlates at the interface of cancer and aging research. J Natl Cancer Inst. 2012;104(8):581–9.PubMedCentralPubMedCrossRef Dale W, Mohile SG, Eldadah BA, et al. Biological, clinical, and psychosocial correlates at the interface of cancer and aging research. J Natl Cancer Inst. 2012;104(8):581–9.PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Hurria A, Wildes T, Blair SL, et al. Senior adult oncology, version 2.2014: clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2014;12(1):82–126.PubMed Hurria A, Wildes T, Blair SL, et al. Senior adult oncology, version 2.2014: clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2014;12(1):82–126.PubMed
8.
Zurück zum Zitat Ingram S, Seo PH, Martell RE, Clipp EC, Doyle ME, Montana GS, et al. Comprehensive assessment of the elderly cancer patient: the feasibility of self-report methodology. J Clin Oncol. 2002;20(3):770–5.PubMedCrossRef Ingram S, Seo PH, Martell RE, Clipp EC, Doyle ME, Montana GS, et al. Comprehensive assessment of the elderly cancer patient: the feasibility of self-report methodology. J Clin Oncol. 2002;20(3):770–5.PubMedCrossRef
9.
Zurück zum Zitat Hurria A, Gupta S, Zauderer M, et al. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer. 2005;104(9):1998–2005.PubMedCrossRef Hurria A, Gupta S, Zauderer M, et al. Developing a cancer-specific geriatric assessment: a feasibility study. Cancer. 2005;104(9):1998–2005.PubMedCrossRef
10.
Zurück zum Zitat Hurria A. Incorporation of geriatric principles in oncology clinical trials. J Clin Oncol. 2007;25(34):5350–1.PubMedCrossRef Hurria A. Incorporation of geriatric principles in oncology clinical trials. J Clin Oncol. 2007;25(34):5350–1.PubMedCrossRef
11.
Zurück zum Zitat Repetto L, Fratino L, Audisio RA, et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol. 2002;20(2):494–502.PubMedCrossRef Repetto L, Fratino L, Audisio RA, et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol. 2002;20(2):494–502.PubMedCrossRef
12.
Zurück zum Zitat Extermann M, Aapro M. Assessment of the older cancer patient. Hematol Oncol Clin N Am. 2000;14(1):63–77. viii–ix.CrossRef Extermann M, Aapro M. Assessment of the older cancer patient. Hematol Oncol Clin N Am. 2000;14(1):63–77. viii–ix.CrossRef
13.
Zurück zum Zitat Mohile SG, Bylow K, Dale W, et al. A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation. Cancer. 2007;109(4):802–10.PubMedCrossRef Mohile SG, Bylow K, Dale W, et al. A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation. Cancer. 2007;109(4):802–10.PubMedCrossRef
14.
Zurück zum Zitat Koroukian SM, Murray P, Madigan E. Comorbidity, disability, and geriatric syndromes in elderly cancer patients receiving home health care. J Clin Oncol. 2006;24(15):2304–10.PubMedCrossRef Koroukian SM, Murray P, Madigan E. Comorbidity, disability, and geriatric syndromes in elderly cancer patients receiving home health care. J Clin Oncol. 2006;24(15):2304–10.PubMedCrossRef
15.
Zurück zum Zitat Mohile SG, Xian Y, Dale W, et al. Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries. J Natl Cancer Inst. 2009;101(17):1206–15.PubMedCentralPubMedCrossRef Mohile SG, Xian Y, Dale W, et al. Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries. J Natl Cancer Inst. 2009;101(17):1206–15.PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Extermann M, Hurria A. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol. 2007;25(14):1824–31.PubMedCrossRef Extermann M, Hurria A. Comprehensive geriatric assessment for older patients with cancer. J Clin Oncol. 2007;25(14):1824–31.PubMedCrossRef
17.••
Zurück zum Zitat Extermann M, Boler I, Reich RR, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. Nov 9 2011. This article demonstrates predictive ability of GA. Extermann M, Boler I, Reich RR, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score. Cancer. Nov 9 2011. This article demonstrates predictive ability of GA.
18.
Zurück zum Zitat Pal SK, Katheria V, Hurria A. Evaluating the older patient with cancer: understanding frailty and the geriatric assessment. CA Cancer J Clin. 2010;60(2):120–32.PubMedCrossRef Pal SK, Katheria V, Hurria A. Evaluating the older patient with cancer: understanding frailty and the geriatric assessment. CA Cancer J Clin. 2010;60(2):120–32.PubMedCrossRef
19.
Zurück zum Zitat Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of adl: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914–9.PubMedCrossRef Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of adl: a standardized measure of biological and psychosocial function. JAMA. 1963;185:914–9.PubMedCrossRef
20.
Zurück zum Zitat Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179–86.PubMedCrossRef Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9(3):179–86.PubMedCrossRef
21.
Zurück zum Zitat Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol Mar. 1994;49(2):M85–94.CrossRef Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol Mar. 1994;49(2):M85–94.CrossRef
22.
Zurück zum Zitat Podsiadlo D, Richardson S. The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142–8.PubMed Podsiadlo D, Richardson S. The timed "Up & Go": a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142–8.PubMed
23.
Zurück zum Zitat Repetto L, Comandini D, Mammoliti S. Life expectancy, comorbidity and quality of life: the treatment equation in the older cancer patients. Crit Rev Oncol Hematol. 2001;37(2):147–52.PubMedCrossRef Repetto L, Comandini D, Mammoliti S. Life expectancy, comorbidity and quality of life: the treatment equation in the older cancer patients. Crit Rev Oncol Hematol. 2001;37(2):147–52.PubMedCrossRef
24.
Zurück zum Zitat Lee JJ, Swain SM. Peripheral neuropathy induced by microtubule-stabilizing agents. J Clin Oncol. 2006;24(10):1633–42.PubMedCrossRef Lee JJ, Swain SM. Peripheral neuropathy induced by microtubule-stabilizing agents. J Clin Oncol. 2006;24(10):1633–42.PubMedCrossRef
25.
Zurück zum Zitat Gewandter JS, Fan L, Magnuson A, et al. Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study. Support Care Cancer. 2013;21(7):2059–66.PubMedCentralPubMedCrossRef Gewandter JS, Fan L, Magnuson A, et al. Falls and functional impairments in cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): a University of Rochester CCOP study. Support Care Cancer. 2013;21(7):2059–66.PubMedCentralPubMedCrossRef
26.
Zurück zum Zitat Sheridan J, Walsh P, Kevans D, et al. Determinants of short- and long-term survival from colorectal cancer in very elderly patients. J Geriatr Oncol. May 17 2014. Sheridan J, Walsh P, Kevans D, et al. Determinants of short- and long-term survival from colorectal cancer in very elderly patients. J Geriatr Oncol. May 17 2014.
27.
Zurück zum Zitat Jorgensen TLHJ, Land LH, Herrstedt J. Comorbidity and polypharmacy in elderly cancer patients: the significant on treatment outcome and tolerance. J Geriatr Oncol. 2010;1(2):87–102.CrossRef Jorgensen TLHJ, Land LH, Herrstedt J. Comorbidity and polypharmacy in elderly cancer patients: the significant on treatment outcome and tolerance. J Geriatr Oncol. 2010;1(2):87–102.CrossRef
28.
Zurück zum Zitat Prithviraj GKKS, Margevicius S, Berger NA, Bagai R, Owusu C. Patient characteritics associated with polypharmacy and inappropriate prescribing of medications among older adults with cancer. J Geriatr Oncol. 2012;3(3):228–37.PubMedCentralPubMedCrossRef Prithviraj GKKS, Margevicius S, Berger NA, Bagai R, Owusu C. Patient characteritics associated with polypharmacy and inappropriate prescribing of medications among older adults with cancer. J Geriatr Oncol. 2012;3(3):228–37.PubMedCentralPubMedCrossRef
29.
Zurück zum Zitat Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern cooperative oncology group. Am J Med. 1980;69(4):491–7.PubMedCrossRef Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern cooperative oncology group. Am J Med. 1980;69(4):491–7.PubMedCrossRef
30.
Zurück zum Zitat Kanesvaran R, Li H, Koo KN, Poon D. Analysis of prognostic factors of comprehensive geriatric assessment and development of a clinical scoring system in elderly Asian patients with cancer. J Clin Oncol. 2011;29(27):3620–7.PubMedCrossRef Kanesvaran R, Li H, Koo KN, Poon D. Analysis of prognostic factors of comprehensive geriatric assessment and development of a clinical scoring system in elderly Asian patients with cancer. J Clin Oncol. 2011;29(27):3620–7.PubMedCrossRef
31.
Zurück zum Zitat Aaldriks AA, van der Geest LG, Giltay EJ, et al. Frailty and malnutrition predictive of mortality risk in older patients with advanced colorectal cancer receiving chemotherapy. J Geriatr Oncol. 2013;4(3):218–26.PubMedCrossRef Aaldriks AA, van der Geest LG, Giltay EJ, et al. Frailty and malnutrition predictive of mortality risk in older patients with advanced colorectal cancer receiving chemotherapy. J Geriatr Oncol. 2013;4(3):218–26.PubMedCrossRef
32.
Zurück zum Zitat Gupta SK, Lamont EB. Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia. J Am Geriatr Soc. 2004;52(10):1681–7.PubMedCrossRef Gupta SK, Lamont EB. Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia. J Am Geriatr Soc. 2004;52(10):1681–7.PubMedCrossRef
33.
Zurück zum Zitat Gorin SS, Heck JE, Albert S, Hershman D. Treatment for breast cancer in patients with Alzheimer's disease. J Am Geriatr Soc. 2005;53(11):1897–904.PubMedCrossRef Gorin SS, Heck JE, Albert S, Hershman D. Treatment for breast cancer in patients with Alzheimer's disease. J Am Geriatr Soc. 2005;53(11):1897–904.PubMedCrossRef
34.
Zurück zum Zitat Goodwin JS, Samet JM, Hunt WC. Determinants of survival in older cancer patients. J Natl Cancer Inst. 1996;88(15):1031–8.PubMedCrossRef Goodwin JS, Samet JM, Hunt WC. Determinants of survival in older cancer patients. J Natl Cancer Inst. 1996;88(15):1031–8.PubMedCrossRef
35.
Zurück zum Zitat Luciani A, Jacobsen PB, Extermann M, et al. Fatigue and functional dependence in older cancer patients. Am J Clin Oncol. 2008;31(5):424–30.PubMedCrossRef Luciani A, Jacobsen PB, Extermann M, et al. Fatigue and functional dependence in older cancer patients. Am J Clin Oncol. 2008;31(5):424–30.PubMedCrossRef
36.
Zurück zum Zitat Freyer G, Geay JF, Touzet S, et al. Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Ann Oncol ESMO. 2005;16(11):1795–800.CrossRef Freyer G, Geay JF, Touzet S, et al. Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Ann Oncol ESMO. 2005;16(11):1795–800.CrossRef
37.•
Zurück zum Zitat Caillet P, Canoui-Poitrine F, Vouriot J, et al. Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study. J Clin Oncol. 2011;29(27):3636–42. This article demonstrates that GA influences decision-making.PubMedCrossRef Caillet P, Canoui-Poitrine F, Vouriot J, et al. Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer: ELCAPA study. J Clin Oncol. 2011;29(27):3636–42. This article demonstrates that GA influences decision-making.PubMedCrossRef
38.
Zurück zum Zitat Horgan AM, Leighl NB, Coate L, et al. Impact and feasibility of a comprehensive geriatric assessment in the oncology setting: a pilot study. Am J Clin Oncol. Mar 17 2011. Horgan AM, Leighl NB, Coate L, et al. Impact and feasibility of a comprehensive geriatric assessment in the oncology setting: a pilot study. Am J Clin Oncol. Mar 17 2011.
39.
Zurück zum Zitat Saliba D, Orlando M, Wenger NS, Hays RD, Rubenstein LZ. Identifying a short functional disability screen for older persons. J Gerontol A Biol Sci Med Sci. 2000;55(12):M750–6.PubMedCrossRef Saliba D, Orlando M, Wenger NS, Hays RD, Rubenstein LZ. Identifying a short functional disability screen for older persons. J Gerontol A Biol Sci Med Sci. 2000;55(12):M750–6.PubMedCrossRef
40.
Zurück zum Zitat Saliba D, Elliott M, Rubenstein LZ, et al. The vulnerable elders survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc. 2001;49(12):1691–9.PubMedCrossRef Saliba D, Elliott M, Rubenstein LZ, et al. The vulnerable elders survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc. 2001;49(12):1691–9.PubMedCrossRef
41.
Zurück zum Zitat Min LC, Elliott MN, Wenger NS, Saliba D. Higher vulnerable elders survey scores predict death and functional decline in vulnerable older people. J Am Geriatr Soc. 2006;54(3):507–11.PubMedCrossRef Min LC, Elliott MN, Wenger NS, Saliba D. Higher vulnerable elders survey scores predict death and functional decline in vulnerable older people. J Am Geriatr Soc. 2006;54(3):507–11.PubMedCrossRef
42.
Zurück zum Zitat Min L, Yoon W, Mariano J, et al. The vulnerable elders-13 survey predicts 5-year functional decline and mortality outcomes in older ambulatory care patients. J Am Geriatr Soc. 2009;57(11):2070–6.PubMedCentralPubMedCrossRef Min L, Yoon W, Mariano J, et al. The vulnerable elders-13 survey predicts 5-year functional decline and mortality outcomes in older ambulatory care patients. J Am Geriatr Soc. 2009;57(11):2070–6.PubMedCentralPubMedCrossRef
43.
Zurück zum Zitat Luciani A, Ascione G, Bertuzzi C, et al. Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13. J Clin Oncol. 2010;28(12):2046–50.PubMedCrossRef Luciani A, Ascione G, Bertuzzi C, et al. Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13. J Clin Oncol. 2010;28(12):2046–50.PubMedCrossRef
44.
Zurück zum Zitat Steverink NSJ, Schuurmans H, et al. Measuring frailty: developing and testing the GFI (Groningen Frailty Indicator). Gerontologist. 2001;41:236. Steverink NSJ, Schuurmans H, et al. Measuring frailty: developing and testing the GFI (Groningen Frailty Indicator). Gerontologist. 2001;41:236.
45.
Zurück zum Zitat Metzelthin SF, Daniels R, van Rossum E, de Witte L, van den Heuvel WJ, Kempen GI. The psychometric properties of three self-report screening instruments for identifying frail older people in the community. BMC Public Health. 2010;10:176.PubMedCentralPubMedCrossRef Metzelthin SF, Daniels R, van Rossum E, de Witte L, van den Heuvel WJ, Kempen GI. The psychometric properties of three self-report screening instruments for identifying frail older people in the community. BMC Public Health. 2010;10:176.PubMedCentralPubMedCrossRef
47.
Zurück zum Zitat Aaldriks AA, Maartense E, le Cessie S, et al. Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy. Crit Rev Oncol Hematol. 2011;79(2):205–12.PubMedCrossRef Aaldriks AA, Maartense E, le Cessie S, et al. Predictive value of geriatric assessment for patients older than 70 years, treated with chemotherapy. Crit Rev Oncol Hematol. 2011;79(2):205–12.PubMedCrossRef
48.
Zurück zum Zitat Soubeyran P BC, Goyard J, et al. Validation of the G8 screening tool in geriatric oncology: The ONCODAGE project. J Clin Oncol. 2011;29 (suppl; abstr 9001). Soubeyran P BC, Goyard J, et al. Validation of the G8 screening tool in geriatric oncology: The ONCODAGE project. J Clin Oncol. 2011;29 (suppl; abstr 9001).
49.
Zurück zum Zitat Magnuson AAJ, Dale W, Fan L, Mohile S. Feasibility of Integrating Comprehensive Geriatric Assessment-Driven Interventions into Standard Oncology Practice in Real Time. Paper presented at: Symposium on Geriatric Assessment in the Oncology Setting and Related Issues in Geriatric Oncology 2011; Toronto, Canada. Magnuson AAJ, Dale W, Fan L, Mohile S. Feasibility of Integrating Comprehensive Geriatric Assessment-Driven Interventions into Standard Oncology Practice in Real Time. Paper presented at: Symposium on Geriatric Assessment in the Oncology Setting and Related Issues in Geriatric Oncology 2011; Toronto, Canada.
50.
Zurück zum Zitat Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968;114(512):797–811.PubMedCrossRef Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968;114(512):797–811.PubMedCrossRef
51.
Zurück zum Zitat Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.PubMedCrossRef Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.PubMedCrossRef
Metadaten
Titel
Models of Care in Geriatric Oncology
verfasst von
Allison Magnuson
William Dale
Supriya Mohile
Publikationsdatum
01.09.2014
Verlag
Springer US
Erschienen in
Current Geriatrics Reports / Ausgabe 3/2014
Elektronische ISSN: 2196-7865
DOI
https://doi.org/10.1007/s13670-014-0095-4

Weitere Artikel der Ausgabe 3/2014

Current Geriatrics Reports 3/2014 Zur Ausgabe

Geriatric Oncology (TM Wildes, Section Editor)

Lung Cancer in Older Adults

Geriatric Oncology (TM Wildes, Section Editor)

Endometrial Cancer in the Elderly

Physical Therapy and Rehabilitation (J Richardson, Section Editor)

Rehabilitation Considerations for the Older Adult with Heart Failure: A Review of the Literature

Geriatric Oncology (TM Wildes, Section Editor)

Colon Cancer in Older Adults: A Primer for Geriatricians

Geriatric Oncology (TM Wildes, Section Editor)

Multiple Myeloma in Older Adults

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.